CA2257622C - Substitutes for modified starch in paper manufacture - Google Patents
Substitutes for modified starch in paper manufacture Download PDFInfo
- Publication number
- CA2257622C CA2257622C CA002257622A CA2257622A CA2257622C CA 2257622 C CA2257622 C CA 2257622C CA 002257622 A CA002257622 A CA 002257622A CA 2257622 A CA2257622 A CA 2257622A CA 2257622 C CA2257622 C CA 2257622C
- Authority
- CA
- Canada
- Prior art keywords
- plant
- glucan
- paper
- maize
- expression cassette
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 30
- 229920000881 Modified starch Polymers 0.000 title abstract description 13
- 235000019426 modified starch Nutrition 0.000 title abstract description 12
- 239000004368 Modified starch Substances 0.000 title abstract description 8
- 229920001503 Glucan Polymers 0.000 claims abstract description 61
- 238000000034 method Methods 0.000 claims abstract description 33
- 238000000576 coating method Methods 0.000 claims abstract description 29
- 239000011248 coating agent Substances 0.000 claims abstract description 27
- 241000194019 Streptococcus mutans Species 0.000 claims abstract description 18
- 108010076450 glucosyltransferase C Proteins 0.000 claims abstract description 11
- 241000196324 Embryophyta Species 0.000 claims description 54
- 229920002472 Starch Polymers 0.000 claims description 51
- 235000019698 starch Nutrition 0.000 claims description 50
- 239000008107 starch Substances 0.000 claims description 46
- 210000004027 cell Anatomy 0.000 claims description 41
- 108090000623 proteins and genes Proteins 0.000 claims description 39
- 240000008042 Zea mays Species 0.000 claims description 22
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims description 20
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 20
- 235000009973 maize Nutrition 0.000 claims description 20
- 239000013598 vector Substances 0.000 claims description 17
- 239000002002 slurry Substances 0.000 claims description 16
- 230000015572 biosynthetic process Effects 0.000 claims description 14
- 244000061456 Solanum tuberosum Species 0.000 claims description 10
- 238000004513 sizing Methods 0.000 claims description 10
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 9
- 210000002706 plastid Anatomy 0.000 claims description 9
- 230000009261 transgenic effect Effects 0.000 claims description 9
- 210000003934 vacuole Anatomy 0.000 claims description 7
- 229920002494 Zein Polymers 0.000 claims description 5
- 239000005019 zein Substances 0.000 claims description 5
- 229940093612 zein Drugs 0.000 claims description 5
- 244000017020 Ipomoea batatas Species 0.000 claims description 4
- 235000002678 Ipomoea batatas Nutrition 0.000 claims description 4
- 240000003183 Manihot esculenta Species 0.000 claims description 4
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 claims description 4
- 240000000111 Saccharum officinarum Species 0.000 claims description 4
- 235000007201 Saccharum officinarum Nutrition 0.000 claims description 4
- 108020004707 nucleic acids Proteins 0.000 claims description 4
- 102000039446 nucleic acids Human genes 0.000 claims description 4
- 150000007523 nucleic acids Chemical class 0.000 claims description 4
- 230000002950 deficient Effects 0.000 claims description 3
- 230000001131 transforming effect Effects 0.000 claims description 3
- 108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 claims description 2
- 108091008324 binding proteins Proteins 0.000 claims description 2
- 229930002875 chlorophyll Natural products 0.000 claims description 2
- 235000019804 chlorophyll Nutrition 0.000 claims description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 claims description 2
- 102000014914 Carrier Proteins Human genes 0.000 claims 1
- 229920001169 thermoplastic Polymers 0.000 abstract description 11
- 239000004416 thermosoftening plastic Substances 0.000 abstract description 11
- 239000000123 paper Substances 0.000 description 43
- 102000004190 Enzymes Human genes 0.000 description 11
- 108090000790 Enzymes Proteins 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 108091028043 Nucleic acid sequence Proteins 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 230000009466 transformation Effects 0.000 description 8
- 238000005755 formation reaction Methods 0.000 description 7
- 229940031008 streptococcus mutans Drugs 0.000 description 7
- 108010055629 Glucosyltransferases Proteins 0.000 description 6
- 102000000340 Glucosyltransferases Human genes 0.000 description 6
- 238000009825 accumulation Methods 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 4
- 238000012512 characterization method Methods 0.000 description 4
- 239000013599 cloning vector Substances 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 101710117545 C protein Proteins 0.000 description 3
- 108700005078 Synthetic Genes Proteins 0.000 description 3
- 238000007385 chemical modification Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 239000000976 ink Substances 0.000 description 3
- 239000004816 latex Substances 0.000 description 3
- 229920000126 latex Polymers 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 229920003043 Cellulose fiber Polymers 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- 239000002174 Styrene-butadiene Substances 0.000 description 2
- MTAZNLWOLGHBHU-UHFFFAOYSA-N butadiene-styrene rubber Chemical compound C=CC=C.C=CC1=CC=CC=C1 MTAZNLWOLGHBHU-UHFFFAOYSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000004009 herbicide Substances 0.000 description 2
- -1 hydroxyethyl group Chemical group 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 210000001938 protoplast Anatomy 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- 239000011115 styrene butadiene Substances 0.000 description 2
- 229920003048 styrene butadiene rubber Polymers 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 101150111062 C gene Proteins 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108700023224 Glucose-1-phosphate adenylyltransferases Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 229920001612 Hydroxyethyl starch Polymers 0.000 description 1
- 108010042889 Inulosucrase Proteins 0.000 description 1
- 108010025815 Kanamycin Kinase Proteins 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 101710091688 Patatin Proteins 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- 108020005091 Replication Origin Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 241000194023 Streptococcus sanguinis Species 0.000 description 1
- 241000193987 Streptococcus sobrinus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000019714 Triticale Nutrition 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 150000001412 amines Chemical group 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000012993 chemical processing Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- VJYIFXVZLXQVHO-UHFFFAOYSA-N chlorsulfuron Chemical compound COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)Cl)=N1 VJYIFXVZLXQVHO-UHFFFAOYSA-N 0.000 description 1
- 238000011098 chromatofocusing Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 108010042194 dextransucrase Proteins 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 229940023064 escherichia coli Drugs 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000011094 fiberboard Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 108090001082 glucan-binding proteins Proteins 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 229940050526 hydroxyethylstarch Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000031787 nutrient reservoir activity Effects 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000001238 wet grinding Methods 0.000 description 1
- 241000228158 x Triticosecale Species 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
- D21H17/00—Non-fibrous material added to the pulp, characterised by its constitution; Paper-impregnating material characterised by its constitution
- D21H17/005—Microorganisms or enzymes
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
- D21H19/00—Coated paper; Coating material
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Paper (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
The present invention provides methods of making paper utilizing glucans, produced by the glucosyltransferase C enzyme of the species Streptococcus mutans, instead of modified starches. The present glucans are functionally similar to the hydroxethyl modified starch and are particularly useful in th e coating step of paper manufacture. The present glucans also exhibit thermoplastic properties and impart gloss to the paper during the coating st ep.
Description
WO 97/47807 PCTr'US96/10191 Field of the Invention The present invention involves the field of paper manufacture. Specifically, the present invention provides sources alternative to modified starch in paper manufacture.
Background of the Invention There are three major phases in paper manufacture where starch is used as an ingredient. The first is the "wet end"
where cellulose fibers are mixed with starch in a slurry, and the slurry is forced through 3 narrow opening onto a wire belt. Water is rapidly removed as the forming sheet travels the length of the belt. After a distance of typically five to fifteen meters on the belt, the sheet has had enough water removed from it so that it can support its own weight. The sheet travels through a number of foils and rolls wherein more water is removed. It is dried to about 11o moisture.
The second phase in paper manufacturing involving starch is the "sizing step". Here, the paper goes through a sizing press where a starch slurry is applied to the sheet.
The sheet again goes through a series of foils and rolls.
It is dried on rollers and can be taken off the press as a finished product.
The third step involves coating the paper with a mixture of starch and a thermoplastic molecule. On certain lines, this occurs after the sizing step. The nascent roll can also be removed and reinstalled onto a different press for coating. A typical coating device has two blades that run the width of the paper. The blades apply the coating material onto two rolling drums. The paper passes between the drums and the coating material, comprising starch and the thermoplastic moiety, comes off the drums onto the paper. After the paper leaves the drums, it goes through a number of dryers. When the paper is dry, it goes onto a "soft calendar" comprising two drums, one made of a hard density fabric and the other a heated steel drum. The paper passes between the two drums and the heated steel drum is sufficiently hot to melt thermoplastic components of the coating mix providing a hard gloss finish on the paper.
The cellulosic wood pulp fibers, typically used in the above process, are anionic in nature. The addition of a cationic starch to the "wet end" slurry acts as an adhesive by cross linking the pulp fibers through salt linkages.
Thus a cross linked polymeric network is made, comprising the starch and cellulose fibers. Typically, the cationic starches used in the "wet end" are tertiary or quaternary amines . These amino groups are added to the starch by wet millers.
Surface sizing starches are used to impart both strength and smooth finish to the sheet after it leaves the "wet end". Such starches also prepare the sheet to receive the various coatings. In cheaper grades of paper and in fiberboard manufacture, sizing starches are used simply as unmodified corn starch. For high grades of paper, chemically-modified starches are used. This is important for the application of a smooth, uniform high quality surface to the paper.
There is a tendency for starches to retrograde i.e. re-form high ordered structures (both helices and crystallites) in an otherwise gelatinous starch slurry. Deposition of retrograded starch onto high quality paper causes regional 3o inconsistencies on the paper and is unacceptable.
Furthermore, retrograded starch in the sizing press may necessitate shutting the line down to clear the apparatus.
The starch most often used for sizing applications is a starch having a covalently attached neutral adduct, for instance hydroxyethyl starch. This is prepared by the reaction of ethylene oxide with starch after it is isolated at the wet milling plant. The function of the hydroxyethyl (or similar) adduct is independent of its chemical nature;
rather, it serves to provide steric hindrance, inhibiting the formation of high ordered structures. This steric hindrance is critical to decrease retrogradation. The periodic protuberance afforded by the adduct disrupts the formation of higher ordered structures that leads to retrogradation.
Speed is of paramount importance in paper manufacturing. Limiting in press speed is starch l0 consistency. Presses often run below their full capacity speeds. Depending on the application, starch slurries are between 3-15'0 (usually 5-6~) solids. An increase in solids would necessarily result in a decrease in the amount of water that would have to be removed from a paper sheet being manufactured. This would allow the press to work at higher speeds.
Hydroxethylated starch also forms higher ordered structures as the temperature decreases or the concentration increases. The formation of the higher ordered structures on the surface of the paper is required. After application to the sheet the starch reforms some of these higher ordered structures and creates a uniform surface that imparts structural strength and facilitates the acceptance of inks and dyes. However, the higher ordered structures should not form in the slurry nor on the application device because this necessitates shutting down the production line to clear off retrograded starch.
The function of the hydroxyethyl group is to lower the temperature and/or raise the concentration of starch at which retrogradation occurs. As the processing lines have already been optimized for a particular temperature of the starch slurry, a decrease in the tendency to retrograde would allow for a higher carbohydrate content in the slurry.
The mixture applied to the paper sheet in the coating process contains hydroxethylated starch and thermoplastic molecules. The most prevalent thermoplastic molecules used are latexes, such as styrene butadiene. The function of the hydroxethyl starch is as indicated above. The function of the thermoplastic molecule is to form a high gloss finish on the paper. This causes an increased ability to take inks and dyes and improves the resolution, in general, on the printed sheet.
Based on the foregoing, there exists a need, in paper manufacturing, for modified starch substitutes which are functionally similar to modified starch. There is a further need to provide substitutes for modified starch which are less prone to retrogradation. There is a further need to provide methods of manufacturing paper which are faster than current methods and allow presses to run closer to their full capacity speed. There is a further need to provide methods of manufacturing paper that are environmentally-friendly and do not involve input materials that require chemical processing.
It is therefore an object of the present invention to provide substitutes for modified starch which are less prone to retrogradation when used in paper manufacture.
It is a further object of the present invention to provide methods of manufacturing paper which are faster and more efficient than existing methods.
It is a further object of the present invention to provide substitutes for starch in paper manufacturing that do not require costly chemical modification as does starch.
It is a further object of the present invention to provide methods for manufacturing paper that are more environmentally-friendly than existing methods.
It is a further object of the present invention to provide substitutes for thermoplastic molecules currently used in the coating step during paper manufacture.
Summary of the Invention The present invention provides glucans which can be used as substitutes for modified starch and latexes in paper manufacture. The present glucans are produced by the glucosyltransferase C ("GTF C") enzyme of the species Strept~coccus mutans, and are functionally sinil..r t:~ the modified.starch currently used in papec manufacture. The present glucans also exhibit similar physical properties r_o thermoplastic molecules currently used in the ceatinq step 5 during paper manufacture.
The present invention also provides methods of mating paper utilizing the present glucans, input materials that are produced biologically. Thus, the present methods are more cost-effective and environmentally-friendly than !0 current methods, which require input materials that produce chemical effluents_ In accordance with one embodiment of the invention there is provided a method of manufacturing paper comprising adding a glucan isolated from a host transformed with a gene encoding a glucosyltransferase C (GTF C) obtained from Streptococcus mutans, to one or more steps of (A) wet ending, (B) sizing, and (C) coating in paper manufacturing. In a further embodiment, the glucan is added to a coating step. In a still further embodiment, the amount of glucan utilized is from about 4 to about 15 weight percent or from about 5 to about 12 weight percent of the slurry used in the coating application.
In another embodiment there is provided a method of imparting gloss on paper during a paper manufacturing process comprising adding a glucan to a coating step, wherein the glucan is synthesized by a glucosyltransferase C enzyme obtained from Streptococcus mutans. In a further embodiment, the amount of glucan utilized is from about 4 to about 15 weight percent or from about 5 to about 12 weight percent of the slurry used in the coating application.
In another embodiment, there is provided a plant expression cassette comprising at least one glucosyltransferase C nucleic acid obtained from Streptococcus mutans operably linked to a promoter that is functional in a plant cell. In a further embodiment, the promoter is a 22 kDa zein, opaque 2, gamma zein, or waxy promoter. The invention further comprises vectors, host cells and transgenic plant cells with this expression cassette.
In another embodiment there is provided a method for producing a glucan in a plant comprising (a) transforming a plant cell with the expression cassette described above, (b) growing the plant cell under plant growing conditions to produce a regenerated plant, and (c) expressing the glucosyltransferase C
nucleic acid for a time sufficient to produce a glucan in the regenerated plant.
Detailed Description of the Invention As used herein "glucan" means a glucose polymer having linkages that are x ( 1--~3) , x ( 1--~6) and branching ac ( 1--~3, 6) .
As used herein "amyloplast" means starch accumulating organelle in plant storage tissue.
As used herein, "vacuole" means the cellular -compartment bounded by the tonoplast membrane. -Streptococcus mutans is a species that is endogenous to the oral cavity and colonizes tooth enamel. See e.g.
Kuramitsu, et al., "Characterization of Extracellular Glucosyl Transferase Activity of Streptococcus-mutans,"
Infect. Immun.; Vol. 12(4); pp. 738-749: (1975): and Yamashita. et al., "Role of the Streptococcus-Mutans-gtf Genes in Caries Induction i~ the Specific-Pathogen-Free Rat Model," Infect. Immun.; Vol. 61(9); pp. 3811-3817; (1993.).
Streptococcus mutans species secrete the glucosyltransferase C ("GTF C") enzyme which utilizes dietary sucrose to make a variety of extracellular glucans. See e.g. Hanada, et al., "Isolation and Characterization of the Streptococcus mutans gtfc Gene, Coding for Synthesis of Both Soluble and Insoluble Glucans," Infect. Immun.; Vol. 56(8); pp. 1999-2005; !19881; and Kametaka, et al., "Purification anti Characterization of Glucosyltransferase from Streptococcus-mutans OMZ176 with Chr~~matof~~wsinq," Microbio~; Vo).
.. w0 X147807 ' PCTIUS96I10191 51(206); pp. 29-36; (1978, Both soluble and insoluble glucans are synthesized, and the proteins responsible have been isolated and characterized. See a.g. Aoki; et al., "Cloning of a Streptococcus-mutans Glucosyltransfe'rase Gene Coding for insoluble Glucan Synthesis" Infect. Immun., Vol. 53 (3);
pp. 587-594; (1986); Shimamura, et al.,."Identification of Amino Acid Residues in Streptococcus mutans Glucosyltransferases Influencing the Structure of the Glucan Produced," J. Bacteriol.; Vol. 276(16); pp, 4845-50; (1994);
and Kametaka, et al., "Purification and Characteriaatiori of Glucosyltransferase from Streptococcus-mutans OMZ176 with Chromatofocusing," Microbios; Vol. S1 (206); pp. 29-36;
(1987) ., The proteins involved are large 0155 kDa) and catalyze the group transfer of the glucosyl portion of sucrose to an acceptor glucan via ac ( 1--~3 ) and oc ( 1-~6 ) linkages . See e.g. Wenham, et al.; "Regulation of Glucosyl Transferase and Fructosyl Transferase Synthesis by Continuous Cultures of Streptococcus-mutans," J. Gen Microbiol.; Vol. 114 (Part 1);
pp. 117-124; (1979); and Fu, et al., "Maltodextrin Acceptor Reactions. of. Streptococcus-mutans 6715 glucosyltransferases," Garbohydr. Res.; Vol. 217; pp. 210-211; (199i); and Bhattacharjee, et al., "Formation of Alpha - ( L-~& ) , Alpha - ( l--~3 ) , and Alpha ( 1-~2 ) Glycosidic Linkages by Dextransucrase from Streptococcus Sanguis in Acceptor-Dependent Reactions," Carbohydr. Res " VoI. 242; pp. 191-201; (I993) The genes involved in glucan symhesis have been isolated and sequenced. See Shimamura, et al., cited hereinabove and Russel, et al., "Expression of a Gene for Glucan-binding Protein from Streptococcus-mutans in Escherichia-coli," J. Gen. Microbiol.; VoI. 131(2); pp, 295-300; (1985); Russell, et al., "Characterization of Glucosyltrarisferase Expressed from a Streptococcus-Sobrinus WU 97147887 pC'F/tTS96Il0I9I
Gene Cloned in Eseherichia-coli," J. Gen. Microbiol.; Vol.
233 (4} ; pp: 935-944; (198'7} ; and Shiroza, et al ., "Sequence Analysis of the gtfc Gene from Streptococcus mutans," J. Bacteriol.; Vol. l69{9); pp. 4263-4270; {1987}, 5.
The structure of the glucans produced by the GTF C
enzyme is quite heterogeneous with respect to the proportions of oc ( 1-~3 } , oc ( 1-~.6 } and oc { 1-~3, 6} branches present in any given glucan: Transformation of genes which to encode naturally occurring GTF C into plants, such as maize, provides amyloplasts and vacuoles with novel compositions..
GTF C enzyme activity incorporated into the amyloplast and/or vacuole leads to the accumulation of starch and glucan in the same amyloplast and/or vacuole.
15 Retrogradation occurs as portions of starch molecules interact and subsequently form inter- or infra-chain ~he~ices. In a mixture of starch and glucans, the frequency of starch-starch interactions that lead to helix formation is diminished. A paste made from the mixed polymers is less 2o prone to retrogradation as a result. This is especially true in the starch accumulation mutants envisioned as transformation targets where the relative proportion of starch is reduced.
Glucans produced in maize amyloplasts and/or vacuoles 25 by the transgenic GTF C enzyme can function in paper processing without chemical modification, as required of starch. The polymer solution consequently has altered Theological properties and is less prone to retrogradation compared to starch. The glucans are branched and irregular 30 and able to supplant modified starches with comparable or superior efficacy. They do not require any vastly chemical modification as does starch. For coating applications, the present glucans exhibit thermoplastic properties in addition to the above advantages.
35 The wild type of GTF C is useful in producing glucans according to the present ir~vention. The GTF C enzyme is well known. See e.g. Shimamura et al., and Hanada, et al., W0 97/478U7 PCTlUS96/10191 cited hereinabove: The glucans produced are particularly useful as substitutes for modified starches in the coating-step of paper manufacture. The present glucans are also useful as substitutes for thermoplastic molecules such as latex (e. g. styrene butadiene). The subject glucans impact a high gloss finish on the.paper and increase the ability of the paper to .take on dyes and inks and improves the resolution in general on the printed sheet.
The glucans of the present invention are preferably 1o produced in transgenic maize, potato, cassava, sweet potato, rye; barley, wheat, sorghum, oats, millet, triticale, sugarcane and rice. More.preferably, the present glucans~are produced in maize, potato, sugarcane; cassava, and sweet potato. Even more preferably, the present glucans are produced in maize and potato. Most preferably, the present glucans are produced in maize.
In a highly preferred embodiment of the present invention, maize lines deficient in starch biosynthesis are transformed with GTF C genes. Such lines may be naturally occurring maize mutants ( i . a . she, bt2, bt1 ) or transgenic maize engineered so as to accumulate low amounts of starch in the endosperm when compared to wild type maize. See e.g.
Miiller-Rober, et al., "Inhibition of the ADP-glucose Pyrophosphorylase in Transgenic Potatoes Leads to Sugar-Storing Tubers and Influences Tuber Formation and Expression of Tuber Storage Protein Genes," The EMBO Journal; Vol.
21(4); pp. 1229-1238; (1992); and Creech, "Carbohydrate Synthesis in Maize," Advances in Agronomy; Vol. 20; pp. 275-322; (1968) The production of the present glucans is performed according to methods of transformation that are well known in the art, and thus constitute no part of this invention.
The compounds of the present invention are synthesized by insertion of an expression cassette containing a synthetic gene which, when transcribed and translated, yields a GTF
enzyme that produce s the desired glucan. Such empty expression cassettes, providing appropriate regulatory sequences for plant expression of the desired sequence, are also well-known, and the nucleotide sequence for the synthetic gene, either RNA or DNA, can readily be derived from the amino acid sequence for the protein using standard texts and the references provided. The above-mentioned synthetic genes preferably employ plant-preferred codons to enhance expression of the desired protein.
The following description further exemplifies the l0 compositions of this invention and the methods of making and using them. However, it will be understood that other methods, known by those of ordinary skill in the art to be equivalent, can also be employed.
The genes which code for the present enzyme can be inserted into an appropriate expression cassette and introduced into cells of a plant species. Thus, an especially preferred embodiment of this method involves inserting into the genome of the plant a DNA sequence coding for a mutant or wild type in proper reading frame, together with transcription promoter and initiator sequences active in the plant. Transcription and translation of the DNA
sequence under control of the regulatory sequences causes expression of the protein sequence at levels which provide an elevated amount of the protein in the tissues of the plant.
Synthetic DNA sequences can then be prepared which code for the appropriate sequence of amino acids of GTF C
protein, and this synthetic DNA sequence can be inserted into an appropriate plant expression cassette.
Plant expression cassettes and vectors applicable in the present invention are well known in the art. By the term "expression cassette" is meant a complete set of control sequences including promoter, initiation, and termination sequences which function in a plant cell when they flank a structural gene in the proper reading frame. Expression cassettes frequently and preferably contain an assortment of restriction sites suitable for cleavage and insertion of any desired structural gene. It is important that the cloned gene have a start codon in the correct reading frame for the structural sequence.
By the term "vector" herein is meant a DNA sequence which is able to replicate and express a foreign gene in a host cell. Typically, the vector has one or more restriction endonuclease recognition sites which may be cut in a predictable fashion by use of the appropriate enzyme such vectors are preferably constructed to include additional l0 structural gene sequences imparting antibiotic or herbicide resistance, which then serve as markers to identify and separate transformed cells. Preferred markers/selection agents include kanamycin, chlorosulfuron, phosphonothricin, hygromycin and methotrexate. A cell in which the foreign genetic material in a vector is functionally expressed has been "transformed" by the vector and is referred to as a "transformant".
A particularly preferred vector is a plasmid, by which is meant a circular double-stranded DNA molecule which is not a part of the chromosomes of the cell.
As mentioned above, both genomic DNA and cDNA encoding the gene of interest may be used in this invention. The gene of interest may also be constructed partially from a cDNA
clone and partially from a genomic clone. When the gene of interest has been isolated, genetic constructs are made which contain the necessary regulatory sequences to provide for efficient expression of the gene in the host cell.
According to this invention, the genetic construct will contain (a) a genetic sequence coding for the protein or trait of interest and (b) one or more regulatory sequences operably linked on either side of the structural gene of interest. Typically, the regulatory sequences will be selected from the group comprising of promoters and terminators. The regulatory sequences may be from autologous or heterologous sources.
The expression cassette comprising the structural gene for a mutant of this invention operably linked to the _~. ___ _~_. ..
desired control sequences can be ligated into a suitable cloning vector. In general, plasmid or viral (bacteriophage) vectors containing replication and control sequences derived from species compatible with the host cell are used. The cloning vector will typically carry a replication origin, as well as specific genes that are capable of providing phenotypic selection markers in transformed host cells. Typically, genes conferring resistance to antibiotics or selected herbicides are used.
After the genetic material is introduced into the target cells, successfully transformed cells and/or colonies of cells can be isolated by selection on the basis of these markers.
Typically, an intermediate host cell will be used in the practice of this invention to increase the copy number of the cloning vector. With an increased copy number, the vector containing the gene of interest can be isolated in significant quantities for introduction into the desired plant cells. Host cells that can be used in the practice of this invention include prokaryotes, including bacterial hosts such as E. coli, S. typhimurium, and Serratia marcescens. Eukaryotic hosts such as yeast or filamentous fungi may also be used in this invention. Since these hosts are also microorganisms, it will be essential to ensure that plant promoters which do not cause expression of the protein in bacteria are used in the vector.
The isolated cloning vector will then be introduced into the plant cell using any convenient technique, including electroporation (in protoplasts), retroviruses, bombardment, and microinjection into cells from monocotyledonous or dicotyledonous plants in cell or tissue culture to provide transformed plant cells containing as foreign DNA at least one copy of the DNA sequence of the plant expression cassette. Using known techniques, protoplasts can be regenerated and cell or tissue culture can be regenerated to form whole fertile plants which carry and express the gene for a protein according to this y~0 97/47807 P~'/US96I1019I -invention. Accordingly, a highly preferred embodiment of the present.invention is a transformed maize plant, the cells of which contain as foreign DNA at least one copy of the DNA
sequence of an expression cassette of the GTF C protein It will also be appreciated by those of ordinary ski.li v -.
that the plant vectors provided herein can be incorporated into Agrobacterium tumefaciens, which can then be used to transfer the vector into susceptible plaint cells, primarily from dicotyledonous species. Thus, this invention provides a method for introducing GTF C in Agrobacterium tumefaciens-susceptible dicotyledonous plants in which the expression cassette is introduced into the cells by infecting thevcells with Agrobacterium tumefaciens, a plasmid of which has been modified to include a plant expression cassette of this invention.
For example, the potato plant can be transformed via Agrobacterium tumefaciens to produce the present glucans.
The transformation cassette comprises a patatin promoter, followed by the GTF C coding sequence and the neomycin phosphotransferase polyadenylation site/terminator. See e.g: Utsumi, et al., "Expression and Accumulation for Normal and Modified Soybean Glycinins in Potato Tubers," Plant Science; Vol. 102(2); pp. 181-188; (1994); (Limerick).
' . The transgenic cassette is placed into a transformation vector.
For example; BIN19, or derivatives thereof, are useful when transforming via Agrobacterium tumefaciens. See e:g.
Visser, et al., "Transformation of Homozygous Diploid Potato with an Agrobacterium-tuniefaciens Binary Vector System by Adventitious Shoot Regeneration on Leaf and Stem Segments,"
Plant Mol. Biol.; Vol. 12(3); pp. 329-338; (1989)~
For maize transformation vectors, the promoters include any promoter whose expression is specific and limited to endosperm cells. Included are those encoding either 22 kDa zero, opaque2, gamma zero and waxy. These lead into the GTF
WO 97!47807 PCTIUS96110191 C gene and are followed by the endogenous terminator or the heterogeneous PINII terminator.
The GTF C protein is .directed 'to the maize endosperm amyloplast using a suitable transit sequence. Transit sequences useful in directing the enzyme into the amyioplast ' for accumulation within the amyloplast include but are not limited to ribulose biphosphate carboxylase small subunit, waxy, brittle-Z, and chlorophyll AB binding protein. The ' transit sequences are juxtaposed between the promoter and the GTF C coding-sequence and fused in translations! reading frame with the GTF C moiety. Transit sequences useful in directing the enzyme into the vacuole for accumulation within the vacuole-are well known in the art. For vacuolar targeting, see e.g: Ebskamp, et al., "Accumulation of Fructose Polymers in Transgenic Tobacco;" Biotechnology;
Vol: 22: pp~. 272-275; (I994~ . .
For maize transformation and regeneration see e.g.
Armstrong, C., (1994y,~"Regeneration of Plants from Somatic Cell Cultures: Applications far in vitro Genetic Manipulation," The Maize Handbook, Freeling, et al. eds, pp.
663-6?1.
Once a given plant is transformed, the glucans synthesized can be isolated, by standard methods, known to--one skilled in the art. The glucans thus obtained in the transgenic plant can be substituted for modified starches and utilized in the sizing and/or coating steps: For formulations useful in the coating step, see e.g. Heiser, et al., "Starch Formations," Starch and Starch Products in Paper Coating: Kearney, et al., eds., pp. 14?-162; (1990);
Tappi Press~
The present glucans are utilized in an amount of from about 4 to. about 15 weight percent, more preferably from about 5 to about 12 weight percent, also preferably from about 6 to about 8 weight percent. Weight percent is defined as grams of molecule per 100 ml coating solution.
The present glucans are used to replace the starch and/or latex molecules completely; or a starch-glucan or a latex-glucan mixture is used in the slurry. In the coating applicatiozz, the glucan:starch ratio preferably ranges from about 10:90 to about 100:0; more preferably froze about 40:60 to about 100:0; more preferably still from about 60:40 to about 100:0; most preferably about 100:0: The glucan:latex ratio preferably ranges from about 10;80 to about 100:0;
more preferably from about 40:60 to about 100:0; more to preferably still from about 60:40 to about 100:0; most preferably about 100:0.
All publications cited in this application~ are indicative of the level of skill of those skilled in the art to which this invention pertains.
Variations on the above embodiments are within the 20 ability of one of ordinary skill in the art, and such variations do not depart from the scope of the present invention as described in the following claims.
Background of the Invention There are three major phases in paper manufacture where starch is used as an ingredient. The first is the "wet end"
where cellulose fibers are mixed with starch in a slurry, and the slurry is forced through 3 narrow opening onto a wire belt. Water is rapidly removed as the forming sheet travels the length of the belt. After a distance of typically five to fifteen meters on the belt, the sheet has had enough water removed from it so that it can support its own weight. The sheet travels through a number of foils and rolls wherein more water is removed. It is dried to about 11o moisture.
The second phase in paper manufacturing involving starch is the "sizing step". Here, the paper goes through a sizing press where a starch slurry is applied to the sheet.
The sheet again goes through a series of foils and rolls.
It is dried on rollers and can be taken off the press as a finished product.
The third step involves coating the paper with a mixture of starch and a thermoplastic molecule. On certain lines, this occurs after the sizing step. The nascent roll can also be removed and reinstalled onto a different press for coating. A typical coating device has two blades that run the width of the paper. The blades apply the coating material onto two rolling drums. The paper passes between the drums and the coating material, comprising starch and the thermoplastic moiety, comes off the drums onto the paper. After the paper leaves the drums, it goes through a number of dryers. When the paper is dry, it goes onto a "soft calendar" comprising two drums, one made of a hard density fabric and the other a heated steel drum. The paper passes between the two drums and the heated steel drum is sufficiently hot to melt thermoplastic components of the coating mix providing a hard gloss finish on the paper.
The cellulosic wood pulp fibers, typically used in the above process, are anionic in nature. The addition of a cationic starch to the "wet end" slurry acts as an adhesive by cross linking the pulp fibers through salt linkages.
Thus a cross linked polymeric network is made, comprising the starch and cellulose fibers. Typically, the cationic starches used in the "wet end" are tertiary or quaternary amines . These amino groups are added to the starch by wet millers.
Surface sizing starches are used to impart both strength and smooth finish to the sheet after it leaves the "wet end". Such starches also prepare the sheet to receive the various coatings. In cheaper grades of paper and in fiberboard manufacture, sizing starches are used simply as unmodified corn starch. For high grades of paper, chemically-modified starches are used. This is important for the application of a smooth, uniform high quality surface to the paper.
There is a tendency for starches to retrograde i.e. re-form high ordered structures (both helices and crystallites) in an otherwise gelatinous starch slurry. Deposition of retrograded starch onto high quality paper causes regional 3o inconsistencies on the paper and is unacceptable.
Furthermore, retrograded starch in the sizing press may necessitate shutting the line down to clear the apparatus.
The starch most often used for sizing applications is a starch having a covalently attached neutral adduct, for instance hydroxyethyl starch. This is prepared by the reaction of ethylene oxide with starch after it is isolated at the wet milling plant. The function of the hydroxyethyl (or similar) adduct is independent of its chemical nature;
rather, it serves to provide steric hindrance, inhibiting the formation of high ordered structures. This steric hindrance is critical to decrease retrogradation. The periodic protuberance afforded by the adduct disrupts the formation of higher ordered structures that leads to retrogradation.
Speed is of paramount importance in paper manufacturing. Limiting in press speed is starch l0 consistency. Presses often run below their full capacity speeds. Depending on the application, starch slurries are between 3-15'0 (usually 5-6~) solids. An increase in solids would necessarily result in a decrease in the amount of water that would have to be removed from a paper sheet being manufactured. This would allow the press to work at higher speeds.
Hydroxethylated starch also forms higher ordered structures as the temperature decreases or the concentration increases. The formation of the higher ordered structures on the surface of the paper is required. After application to the sheet the starch reforms some of these higher ordered structures and creates a uniform surface that imparts structural strength and facilitates the acceptance of inks and dyes. However, the higher ordered structures should not form in the slurry nor on the application device because this necessitates shutting down the production line to clear off retrograded starch.
The function of the hydroxyethyl group is to lower the temperature and/or raise the concentration of starch at which retrogradation occurs. As the processing lines have already been optimized for a particular temperature of the starch slurry, a decrease in the tendency to retrograde would allow for a higher carbohydrate content in the slurry.
The mixture applied to the paper sheet in the coating process contains hydroxethylated starch and thermoplastic molecules. The most prevalent thermoplastic molecules used are latexes, such as styrene butadiene. The function of the hydroxethyl starch is as indicated above. The function of the thermoplastic molecule is to form a high gloss finish on the paper. This causes an increased ability to take inks and dyes and improves the resolution, in general, on the printed sheet.
Based on the foregoing, there exists a need, in paper manufacturing, for modified starch substitutes which are functionally similar to modified starch. There is a further need to provide substitutes for modified starch which are less prone to retrogradation. There is a further need to provide methods of manufacturing paper which are faster than current methods and allow presses to run closer to their full capacity speed. There is a further need to provide methods of manufacturing paper that are environmentally-friendly and do not involve input materials that require chemical processing.
It is therefore an object of the present invention to provide substitutes for modified starch which are less prone to retrogradation when used in paper manufacture.
It is a further object of the present invention to provide methods of manufacturing paper which are faster and more efficient than existing methods.
It is a further object of the present invention to provide substitutes for starch in paper manufacturing that do not require costly chemical modification as does starch.
It is a further object of the present invention to provide methods for manufacturing paper that are more environmentally-friendly than existing methods.
It is a further object of the present invention to provide substitutes for thermoplastic molecules currently used in the coating step during paper manufacture.
Summary of the Invention The present invention provides glucans which can be used as substitutes for modified starch and latexes in paper manufacture. The present glucans are produced by the glucosyltransferase C ("GTF C") enzyme of the species Strept~coccus mutans, and are functionally sinil..r t:~ the modified.starch currently used in papec manufacture. The present glucans also exhibit similar physical properties r_o thermoplastic molecules currently used in the ceatinq step 5 during paper manufacture.
The present invention also provides methods of mating paper utilizing the present glucans, input materials that are produced biologically. Thus, the present methods are more cost-effective and environmentally-friendly than !0 current methods, which require input materials that produce chemical effluents_ In accordance with one embodiment of the invention there is provided a method of manufacturing paper comprising adding a glucan isolated from a host transformed with a gene encoding a glucosyltransferase C (GTF C) obtained from Streptococcus mutans, to one or more steps of (A) wet ending, (B) sizing, and (C) coating in paper manufacturing. In a further embodiment, the glucan is added to a coating step. In a still further embodiment, the amount of glucan utilized is from about 4 to about 15 weight percent or from about 5 to about 12 weight percent of the slurry used in the coating application.
In another embodiment there is provided a method of imparting gloss on paper during a paper manufacturing process comprising adding a glucan to a coating step, wherein the glucan is synthesized by a glucosyltransferase C enzyme obtained from Streptococcus mutans. In a further embodiment, the amount of glucan utilized is from about 4 to about 15 weight percent or from about 5 to about 12 weight percent of the slurry used in the coating application.
In another embodiment, there is provided a plant expression cassette comprising at least one glucosyltransferase C nucleic acid obtained from Streptococcus mutans operably linked to a promoter that is functional in a plant cell. In a further embodiment, the promoter is a 22 kDa zein, opaque 2, gamma zein, or waxy promoter. The invention further comprises vectors, host cells and transgenic plant cells with this expression cassette.
In another embodiment there is provided a method for producing a glucan in a plant comprising (a) transforming a plant cell with the expression cassette described above, (b) growing the plant cell under plant growing conditions to produce a regenerated plant, and (c) expressing the glucosyltransferase C
nucleic acid for a time sufficient to produce a glucan in the regenerated plant.
Detailed Description of the Invention As used herein "glucan" means a glucose polymer having linkages that are x ( 1--~3) , x ( 1--~6) and branching ac ( 1--~3, 6) .
As used herein "amyloplast" means starch accumulating organelle in plant storage tissue.
As used herein, "vacuole" means the cellular -compartment bounded by the tonoplast membrane. -Streptococcus mutans is a species that is endogenous to the oral cavity and colonizes tooth enamel. See e.g.
Kuramitsu, et al., "Characterization of Extracellular Glucosyl Transferase Activity of Streptococcus-mutans,"
Infect. Immun.; Vol. 12(4); pp. 738-749: (1975): and Yamashita. et al., "Role of the Streptococcus-Mutans-gtf Genes in Caries Induction i~ the Specific-Pathogen-Free Rat Model," Infect. Immun.; Vol. 61(9); pp. 3811-3817; (1993.).
Streptococcus mutans species secrete the glucosyltransferase C ("GTF C") enzyme which utilizes dietary sucrose to make a variety of extracellular glucans. See e.g. Hanada, et al., "Isolation and Characterization of the Streptococcus mutans gtfc Gene, Coding for Synthesis of Both Soluble and Insoluble Glucans," Infect. Immun.; Vol. 56(8); pp. 1999-2005; !19881; and Kametaka, et al., "Purification anti Characterization of Glucosyltransferase from Streptococcus-mutans OMZ176 with Chr~~matof~~wsinq," Microbio~; Vo).
.. w0 X147807 ' PCTIUS96I10191 51(206); pp. 29-36; (1978, Both soluble and insoluble glucans are synthesized, and the proteins responsible have been isolated and characterized. See a.g. Aoki; et al., "Cloning of a Streptococcus-mutans Glucosyltransfe'rase Gene Coding for insoluble Glucan Synthesis" Infect. Immun., Vol. 53 (3);
pp. 587-594; (1986); Shimamura, et al.,."Identification of Amino Acid Residues in Streptococcus mutans Glucosyltransferases Influencing the Structure of the Glucan Produced," J. Bacteriol.; Vol. 276(16); pp, 4845-50; (1994);
and Kametaka, et al., "Purification and Characteriaatiori of Glucosyltransferase from Streptococcus-mutans OMZ176 with Chromatofocusing," Microbios; Vol. S1 (206); pp. 29-36;
(1987) ., The proteins involved are large 0155 kDa) and catalyze the group transfer of the glucosyl portion of sucrose to an acceptor glucan via ac ( 1--~3 ) and oc ( 1-~6 ) linkages . See e.g. Wenham, et al.; "Regulation of Glucosyl Transferase and Fructosyl Transferase Synthesis by Continuous Cultures of Streptococcus-mutans," J. Gen Microbiol.; Vol. 114 (Part 1);
pp. 117-124; (1979); and Fu, et al., "Maltodextrin Acceptor Reactions. of. Streptococcus-mutans 6715 glucosyltransferases," Garbohydr. Res.; Vol. 217; pp. 210-211; (199i); and Bhattacharjee, et al., "Formation of Alpha - ( L-~& ) , Alpha - ( l--~3 ) , and Alpha ( 1-~2 ) Glycosidic Linkages by Dextransucrase from Streptococcus Sanguis in Acceptor-Dependent Reactions," Carbohydr. Res " VoI. 242; pp. 191-201; (I993) The genes involved in glucan symhesis have been isolated and sequenced. See Shimamura, et al., cited hereinabove and Russel, et al., "Expression of a Gene for Glucan-binding Protein from Streptococcus-mutans in Escherichia-coli," J. Gen. Microbiol.; VoI. 131(2); pp, 295-300; (1985); Russell, et al., "Characterization of Glucosyltrarisferase Expressed from a Streptococcus-Sobrinus WU 97147887 pC'F/tTS96Il0I9I
Gene Cloned in Eseherichia-coli," J. Gen. Microbiol.; Vol.
233 (4} ; pp: 935-944; (198'7} ; and Shiroza, et al ., "Sequence Analysis of the gtfc Gene from Streptococcus mutans," J. Bacteriol.; Vol. l69{9); pp. 4263-4270; {1987}, 5.
The structure of the glucans produced by the GTF C
enzyme is quite heterogeneous with respect to the proportions of oc ( 1-~3 } , oc ( 1-~.6 } and oc { 1-~3, 6} branches present in any given glucan: Transformation of genes which to encode naturally occurring GTF C into plants, such as maize, provides amyloplasts and vacuoles with novel compositions..
GTF C enzyme activity incorporated into the amyloplast and/or vacuole leads to the accumulation of starch and glucan in the same amyloplast and/or vacuole.
15 Retrogradation occurs as portions of starch molecules interact and subsequently form inter- or infra-chain ~he~ices. In a mixture of starch and glucans, the frequency of starch-starch interactions that lead to helix formation is diminished. A paste made from the mixed polymers is less 2o prone to retrogradation as a result. This is especially true in the starch accumulation mutants envisioned as transformation targets where the relative proportion of starch is reduced.
Glucans produced in maize amyloplasts and/or vacuoles 25 by the transgenic GTF C enzyme can function in paper processing without chemical modification, as required of starch. The polymer solution consequently has altered Theological properties and is less prone to retrogradation compared to starch. The glucans are branched and irregular 30 and able to supplant modified starches with comparable or superior efficacy. They do not require any vastly chemical modification as does starch. For coating applications, the present glucans exhibit thermoplastic properties in addition to the above advantages.
35 The wild type of GTF C is useful in producing glucans according to the present ir~vention. The GTF C enzyme is well known. See e.g. Shimamura et al., and Hanada, et al., W0 97/478U7 PCTlUS96/10191 cited hereinabove: The glucans produced are particularly useful as substitutes for modified starches in the coating-step of paper manufacture. The present glucans are also useful as substitutes for thermoplastic molecules such as latex (e. g. styrene butadiene). The subject glucans impact a high gloss finish on the.paper and increase the ability of the paper to .take on dyes and inks and improves the resolution in general on the printed sheet.
The glucans of the present invention are preferably 1o produced in transgenic maize, potato, cassava, sweet potato, rye; barley, wheat, sorghum, oats, millet, triticale, sugarcane and rice. More.preferably, the present glucans~are produced in maize, potato, sugarcane; cassava, and sweet potato. Even more preferably, the present glucans are produced in maize and potato. Most preferably, the present glucans are produced in maize.
In a highly preferred embodiment of the present invention, maize lines deficient in starch biosynthesis are transformed with GTF C genes. Such lines may be naturally occurring maize mutants ( i . a . she, bt2, bt1 ) or transgenic maize engineered so as to accumulate low amounts of starch in the endosperm when compared to wild type maize. See e.g.
Miiller-Rober, et al., "Inhibition of the ADP-glucose Pyrophosphorylase in Transgenic Potatoes Leads to Sugar-Storing Tubers and Influences Tuber Formation and Expression of Tuber Storage Protein Genes," The EMBO Journal; Vol.
21(4); pp. 1229-1238; (1992); and Creech, "Carbohydrate Synthesis in Maize," Advances in Agronomy; Vol. 20; pp. 275-322; (1968) The production of the present glucans is performed according to methods of transformation that are well known in the art, and thus constitute no part of this invention.
The compounds of the present invention are synthesized by insertion of an expression cassette containing a synthetic gene which, when transcribed and translated, yields a GTF
enzyme that produce s the desired glucan. Such empty expression cassettes, providing appropriate regulatory sequences for plant expression of the desired sequence, are also well-known, and the nucleotide sequence for the synthetic gene, either RNA or DNA, can readily be derived from the amino acid sequence for the protein using standard texts and the references provided. The above-mentioned synthetic genes preferably employ plant-preferred codons to enhance expression of the desired protein.
The following description further exemplifies the l0 compositions of this invention and the methods of making and using them. However, it will be understood that other methods, known by those of ordinary skill in the art to be equivalent, can also be employed.
The genes which code for the present enzyme can be inserted into an appropriate expression cassette and introduced into cells of a plant species. Thus, an especially preferred embodiment of this method involves inserting into the genome of the plant a DNA sequence coding for a mutant or wild type in proper reading frame, together with transcription promoter and initiator sequences active in the plant. Transcription and translation of the DNA
sequence under control of the regulatory sequences causes expression of the protein sequence at levels which provide an elevated amount of the protein in the tissues of the plant.
Synthetic DNA sequences can then be prepared which code for the appropriate sequence of amino acids of GTF C
protein, and this synthetic DNA sequence can be inserted into an appropriate plant expression cassette.
Plant expression cassettes and vectors applicable in the present invention are well known in the art. By the term "expression cassette" is meant a complete set of control sequences including promoter, initiation, and termination sequences which function in a plant cell when they flank a structural gene in the proper reading frame. Expression cassettes frequently and preferably contain an assortment of restriction sites suitable for cleavage and insertion of any desired structural gene. It is important that the cloned gene have a start codon in the correct reading frame for the structural sequence.
By the term "vector" herein is meant a DNA sequence which is able to replicate and express a foreign gene in a host cell. Typically, the vector has one or more restriction endonuclease recognition sites which may be cut in a predictable fashion by use of the appropriate enzyme such vectors are preferably constructed to include additional l0 structural gene sequences imparting antibiotic or herbicide resistance, which then serve as markers to identify and separate transformed cells. Preferred markers/selection agents include kanamycin, chlorosulfuron, phosphonothricin, hygromycin and methotrexate. A cell in which the foreign genetic material in a vector is functionally expressed has been "transformed" by the vector and is referred to as a "transformant".
A particularly preferred vector is a plasmid, by which is meant a circular double-stranded DNA molecule which is not a part of the chromosomes of the cell.
As mentioned above, both genomic DNA and cDNA encoding the gene of interest may be used in this invention. The gene of interest may also be constructed partially from a cDNA
clone and partially from a genomic clone. When the gene of interest has been isolated, genetic constructs are made which contain the necessary regulatory sequences to provide for efficient expression of the gene in the host cell.
According to this invention, the genetic construct will contain (a) a genetic sequence coding for the protein or trait of interest and (b) one or more regulatory sequences operably linked on either side of the structural gene of interest. Typically, the regulatory sequences will be selected from the group comprising of promoters and terminators. The regulatory sequences may be from autologous or heterologous sources.
The expression cassette comprising the structural gene for a mutant of this invention operably linked to the _~. ___ _~_. ..
desired control sequences can be ligated into a suitable cloning vector. In general, plasmid or viral (bacteriophage) vectors containing replication and control sequences derived from species compatible with the host cell are used. The cloning vector will typically carry a replication origin, as well as specific genes that are capable of providing phenotypic selection markers in transformed host cells. Typically, genes conferring resistance to antibiotics or selected herbicides are used.
After the genetic material is introduced into the target cells, successfully transformed cells and/or colonies of cells can be isolated by selection on the basis of these markers.
Typically, an intermediate host cell will be used in the practice of this invention to increase the copy number of the cloning vector. With an increased copy number, the vector containing the gene of interest can be isolated in significant quantities for introduction into the desired plant cells. Host cells that can be used in the practice of this invention include prokaryotes, including bacterial hosts such as E. coli, S. typhimurium, and Serratia marcescens. Eukaryotic hosts such as yeast or filamentous fungi may also be used in this invention. Since these hosts are also microorganisms, it will be essential to ensure that plant promoters which do not cause expression of the protein in bacteria are used in the vector.
The isolated cloning vector will then be introduced into the plant cell using any convenient technique, including electroporation (in protoplasts), retroviruses, bombardment, and microinjection into cells from monocotyledonous or dicotyledonous plants in cell or tissue culture to provide transformed plant cells containing as foreign DNA at least one copy of the DNA sequence of the plant expression cassette. Using known techniques, protoplasts can be regenerated and cell or tissue culture can be regenerated to form whole fertile plants which carry and express the gene for a protein according to this y~0 97/47807 P~'/US96I1019I -invention. Accordingly, a highly preferred embodiment of the present.invention is a transformed maize plant, the cells of which contain as foreign DNA at least one copy of the DNA
sequence of an expression cassette of the GTF C protein It will also be appreciated by those of ordinary ski.li v -.
that the plant vectors provided herein can be incorporated into Agrobacterium tumefaciens, which can then be used to transfer the vector into susceptible plaint cells, primarily from dicotyledonous species. Thus, this invention provides a method for introducing GTF C in Agrobacterium tumefaciens-susceptible dicotyledonous plants in which the expression cassette is introduced into the cells by infecting thevcells with Agrobacterium tumefaciens, a plasmid of which has been modified to include a plant expression cassette of this invention.
For example, the potato plant can be transformed via Agrobacterium tumefaciens to produce the present glucans.
The transformation cassette comprises a patatin promoter, followed by the GTF C coding sequence and the neomycin phosphotransferase polyadenylation site/terminator. See e.g: Utsumi, et al., "Expression and Accumulation for Normal and Modified Soybean Glycinins in Potato Tubers," Plant Science; Vol. 102(2); pp. 181-188; (1994); (Limerick).
' . The transgenic cassette is placed into a transformation vector.
For example; BIN19, or derivatives thereof, are useful when transforming via Agrobacterium tumefaciens. See e:g.
Visser, et al., "Transformation of Homozygous Diploid Potato with an Agrobacterium-tuniefaciens Binary Vector System by Adventitious Shoot Regeneration on Leaf and Stem Segments,"
Plant Mol. Biol.; Vol. 12(3); pp. 329-338; (1989)~
For maize transformation vectors, the promoters include any promoter whose expression is specific and limited to endosperm cells. Included are those encoding either 22 kDa zero, opaque2, gamma zero and waxy. These lead into the GTF
WO 97!47807 PCTIUS96110191 C gene and are followed by the endogenous terminator or the heterogeneous PINII terminator.
The GTF C protein is .directed 'to the maize endosperm amyloplast using a suitable transit sequence. Transit sequences useful in directing the enzyme into the amyioplast ' for accumulation within the amyloplast include but are not limited to ribulose biphosphate carboxylase small subunit, waxy, brittle-Z, and chlorophyll AB binding protein. The ' transit sequences are juxtaposed between the promoter and the GTF C coding-sequence and fused in translations! reading frame with the GTF C moiety. Transit sequences useful in directing the enzyme into the vacuole for accumulation within the vacuole-are well known in the art. For vacuolar targeting, see e.g: Ebskamp, et al., "Accumulation of Fructose Polymers in Transgenic Tobacco;" Biotechnology;
Vol: 22: pp~. 272-275; (I994~ . .
For maize transformation and regeneration see e.g.
Armstrong, C., (1994y,~"Regeneration of Plants from Somatic Cell Cultures: Applications far in vitro Genetic Manipulation," The Maize Handbook, Freeling, et al. eds, pp.
663-6?1.
Once a given plant is transformed, the glucans synthesized can be isolated, by standard methods, known to--one skilled in the art. The glucans thus obtained in the transgenic plant can be substituted for modified starches and utilized in the sizing and/or coating steps: For formulations useful in the coating step, see e.g. Heiser, et al., "Starch Formations," Starch and Starch Products in Paper Coating: Kearney, et al., eds., pp. 14?-162; (1990);
Tappi Press~
The present glucans are utilized in an amount of from about 4 to. about 15 weight percent, more preferably from about 5 to about 12 weight percent, also preferably from about 6 to about 8 weight percent. Weight percent is defined as grams of molecule per 100 ml coating solution.
The present glucans are used to replace the starch and/or latex molecules completely; or a starch-glucan or a latex-glucan mixture is used in the slurry. In the coating applicatiozz, the glucan:starch ratio preferably ranges from about 10:90 to about 100:0; more preferably froze about 40:60 to about 100:0; more preferably still from about 60:40 to about 100:0; most preferably about 100:0: The glucan:latex ratio preferably ranges from about 10;80 to about 100:0;
more preferably from about 40:60 to about 100:0; more to preferably still from about 60:40 to about 100:0; most preferably about 100:0.
All publications cited in this application~ are indicative of the level of skill of those skilled in the art to which this invention pertains.
Variations on the above embodiments are within the 20 ability of one of ordinary skill in the art, and such variations do not depart from the scope of the present invention as described in the following claims.
Claims (25)
1. A method of manufacturing paper comprising adding a glucan isolated from a host transformed with a gene encoding a glucosyltransferase C (GTF C) obtained from Streptococcus mutans, to one or more steps of (A) wet ending, (B) sizing, and (C) coating in paper manufacturing.
2. The method of the Claim 1 wherein the glucan is added to a coating step.
3. The method of Claim 2 wherein the amount of glucan utilized is from about 4 to about 15 weight percent of a slurry used in the coating application.
4. The method of Claim 3 wherein the amount of glucan utilized is from about 5 to about 12 weight percent of the slurry used in the coating application.
5. A method of imparting gloss on paper during a paper manufacturing process comprising adding a glucan to a coating step, wherein the glucan is synthesized by a glucosyltransferase C enzyme obtained from Streptococcus mutans.
6. The method of Claim 5 wherein the amount of glucan utilized is from about 4 to about 15 weight percent of a slurry used in the coating application.
7. The method of Claim 6 wherein the amount of glucan utilized is from about 5 to about 12 weight percent of the slurry used in the coating application.
8. A plant expression cassette comprising at least one glucosyltransferase C
nucleic acid obtained from Streptococcus mutans operably linked to a promoter that is functional in a plant cell.
nucleic acid obtained from Streptococcus mutans operably linked to a promoter that is functional in a plant cell.
9. The expression cassette of Claim 8, wherein the promoter is a 22 kDa zero, opaque 2, gamma zein, or waxy promoter.
10. A vector comprising the expression cassette of Claim 8.
11. A host cell introduced with at least one expression cassette of Claim 8.
12. The host cell of Claim 11 that is a plant cell.
13. A cell of a transgenic plant comprising at least one expression cassette of Claim 8.
14. The plant cell of Claim 13, wherein the plant is maize, potato, sugar cane, cassava or sweet potato.
15. The plant cell of claim 14 which is maize.
16. The plant cell of claim 15 wherein the maize is deficient in starch biosynthesis.
17. The plant cell of claim 16 which is selected from the group consisting of sh2, bt, and bt2.
18. A method for producing a glucan in a plant comprising:
(a) transforming a plant cell with the expression cassette of Claim 8; and (b) growing the plant cell under plant growing conditions to produce a regenerated plant.
(c) expressing the glucosyltransferase C nucleic acid for a time sufficient to produce a glucan in the regenerated plant.
(a) transforming a plant cell with the expression cassette of Claim 8; and (b) growing the plant cell under plant growing conditions to produce a regenerated plant.
(c) expressing the glucosyltransferase C nucleic acid for a time sufficient to produce a glucan in the regenerated plant.
19. The method of Claim 18 wherein the plant is maize, potato, sugar cane, cassava or sweet potato.
20. The method of Claim 18 wherein the plant is a maize plant that is deficient in starch biosynthesis.
21. The method of Claim 20 wherein the plant is sh2, bt1, or bt2.
22. The method of Claim 18 wherein the promoter is selected from the group consisting of 22 kDa zein, opaque 2, gamma zein and waxy promoter.
23. The method of Claim 18 wherein the expression cassette contains a transit sequence selected from the group consisting of ribulose biphosphate carboxylase small subunit, waxy, brittle-1 and chlorophyll AB binding protein.
24. The method of Claim 23 wherein a glucan is produced in the amyloplast or vacuole of the plant cell.
25. The method of Claim 24 wherein the glucan is produced in the amyloplast of maize or potato.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1996/010191 WO1997047807A1 (en) | 1996-06-12 | 1996-06-12 | Substitutes for modified starch in paper manufacture |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2257622A1 CA2257622A1 (en) | 1997-12-18 |
| CA2257622C true CA2257622C (en) | 2003-02-11 |
Family
ID=22255318
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002257622A Expired - Fee Related CA2257622C (en) | 1996-06-12 | 1996-06-12 | Substitutes for modified starch in paper manufacture |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0904454A1 (en) |
| JP (1) | JP2000512348A (en) |
| AU (1) | AU729286B2 (en) |
| CA (1) | CA2257622C (en) |
| WO (1) | WO1997047807A1 (en) |
Families Citing this family (178)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CL2007003744A1 (en) | 2006-12-22 | 2008-07-11 | Bayer Cropscience Ag | COMPOSITION THAT INCLUDES A 2-PYRIDILMETILBENZAMIDE DERIVATIVE AND AN INSECTICIDE COMPOUND; AND METHOD TO CONTROL FITOPATOGENOS CULTURES AND INSECTS FACING OR PREVENTIVELY. |
| CL2007003743A1 (en) | 2006-12-22 | 2008-07-11 | Bayer Cropscience Ag | COMPOSITION THAT INCLUDES FENAMIDONA AND AN INSECTICIDE COMPOUND; AND METHOD TO CONTROL FITOPATOGENOS CULTURES AND INSECTS FACING OR PREVENTIVELY. |
| EP1969934A1 (en) | 2007-03-12 | 2008-09-17 | Bayer CropScience AG | 4-cycloalkyl or 4-aryl substituted phenoxy phenylamidines and their use as fungicides |
| EP1969929A1 (en) | 2007-03-12 | 2008-09-17 | Bayer CropScience AG | Substituted phenylamidines and their use as fungicides |
| BRPI0808846A2 (en) | 2007-03-12 | 2019-09-24 | Bayer Cropscience Ag | 3-substituted phenoxyphenylamidines and their use as fungicides |
| BRPI0808798A2 (en) | 2007-03-12 | 2014-10-07 | Bayer Cropscience Ag | 3,5-DISSUBSTITUTED PHENOXYPHENYLAMIDINS AND THEIR USE AS FUNGICIDES |
| JP2010520899A (en) | 2007-03-12 | 2010-06-17 | バイエル・クロツプサイエンス・アクチエンゲゼルシヤフト | Dihalophenoxyphenylamidine and its use as a fungicide |
| EP1969930A1 (en) | 2007-03-12 | 2008-09-17 | Bayer CropScience AG | Phenoxy phenylamidines and their use as fungicides |
| US8168567B2 (en) | 2007-04-19 | 2012-05-01 | Bayer Cropscience Ag | Thiadiazolyl oxyphenyl amidines and the use thereof as a fungicide |
| DE102007045956A1 (en) | 2007-09-26 | 2009-04-09 | Bayer Cropscience Ag | Combination of active ingredients with insecticidal and acaricidal properties |
| DE102007045922A1 (en) | 2007-09-26 | 2009-04-02 | Bayer Cropscience Ag | Drug combinations with insecticidal and acaricidal properties |
| DE102007045953B4 (en) | 2007-09-26 | 2018-07-05 | Bayer Intellectual Property Gmbh | Drug combinations with insecticidal and acaricidal properties |
| DE102007045920B4 (en) | 2007-09-26 | 2018-07-05 | Bayer Intellectual Property Gmbh | Synergistic drug combinations |
| DE102007045919B4 (en) | 2007-09-26 | 2018-07-05 | Bayer Intellectual Property Gmbh | Drug combinations with insecticidal and acaricidal properties |
| EP2090168A1 (en) | 2008-02-12 | 2009-08-19 | Bayer CropScience AG | Method for improving plant growth |
| EP2072506A1 (en) | 2007-12-21 | 2009-06-24 | Bayer CropScience AG | Thiazolyloxyphenylamidine or thiadiazolyloxyphenylamidine und its use as fungicide |
| EP2168434A1 (en) | 2008-08-02 | 2010-03-31 | Bayer CropScience AG | Use of azols to increase resistance of plants of parts of plants to abiotic stress |
| EP2374791A1 (en) | 2008-08-14 | 2011-10-12 | Bayer CropScience Aktiengesellschaft | Insecticidal 4-phenyl-1H pyrazoles |
| DE102008041695A1 (en) | 2008-08-29 | 2010-03-04 | Bayer Cropscience Ag | Methods for improving plant growth |
| EP2201838A1 (en) | 2008-12-05 | 2010-06-30 | Bayer CropScience AG | Active ingredient-beneficial organism combinations with insecticide and acaricide properties |
| EP2198709A1 (en) | 2008-12-19 | 2010-06-23 | Bayer CropScience AG | Method for treating resistant animal pests |
| EP2204094A1 (en) | 2008-12-29 | 2010-07-07 | Bayer CropScience AG | Method for improved utilization of the production potential of transgenic plants Introduction |
| EP2223602A1 (en) | 2009-02-23 | 2010-09-01 | Bayer CropScience AG | Method for improved utilisation of the production potential of genetically modified plants |
| EP2381781B1 (en) | 2008-12-29 | 2016-06-08 | Bayer Intellectual Property GmbH | Method for improved use of the production potential of genetically modified plants |
| EP2039772A2 (en) | 2009-01-06 | 2009-03-25 | Bayer CropScience AG | Method for improved utilization of the production potential of transgenic plants introduction |
| EP2039770A2 (en) | 2009-01-06 | 2009-03-25 | Bayer CropScience AG | Method for improved utilization of the production potential of transgenic plants |
| EP2039771A2 (en) | 2009-01-06 | 2009-03-25 | Bayer CropScience AG | Method for improved utilization of the production potential of transgenic plants |
| WO2010081689A2 (en) | 2009-01-19 | 2010-07-22 | Bayer Cropscience Ag | Cyclic diones and their use as insecticides, acaricides and/or fungicides |
| EP2227951A1 (en) | 2009-01-23 | 2010-09-15 | Bayer CropScience AG | Application of enaminocarbonyl compounds for combating viruses transmitted by insects |
| WO2010086311A1 (en) | 2009-01-28 | 2010-08-05 | Bayer Cropscience Ag | Fungicide n-cycloalkyl-n-bicyclicmethylene-carboxamide derivatives |
| AR075126A1 (en) | 2009-01-29 | 2011-03-09 | Bayer Cropscience Ag | METHOD FOR THE BEST USE OF THE TRANSGENIC PLANTS PRODUCTION POTENTIAL |
| EP2398770B1 (en) | 2009-02-17 | 2016-12-28 | Bayer Intellectual Property GmbH | Fungicidal n-(phenylcycloalkyl)carboxamide, n-(benzylcycloalkyl)carboxamide and thiocarboxamide derivatives |
| EP2218717A1 (en) | 2009-02-17 | 2010-08-18 | Bayer CropScience AG | Fungicidal N-((HET)Arylethyl)thiocarboxamide derivatives |
| TW201031331A (en) | 2009-02-19 | 2010-09-01 | Bayer Cropscience Ag | Pesticide composition comprising a tetrazolyloxime derivative and a fungicide or an insecticide active substance |
| EP2410849A1 (en) | 2009-03-25 | 2012-02-01 | Bayer CropScience AG | Active ingredient combinations having insecticidal and acaricidal properties |
| CN102448304B (en) | 2009-03-25 | 2015-03-11 | 拜尔农作物科学股份公司 | Active ingredient combinations having insecticidal and acaricidal properties |
| NZ595345A (en) | 2009-03-25 | 2014-01-31 | Bayer Cropscience Ag | Active ingredient combinations with insecticidal and acaricidal properties |
| UA104887C2 (en) | 2009-03-25 | 2014-03-25 | Баєр Кропсаєнс Аг | Synergic combinations of active ingredients |
| BRPI0924451B1 (en) | 2009-03-25 | 2017-12-26 | Bayer Intellectual Property Gmbh | Combinations of active substances and their uses, as well as methods for the control of animal pests and method for the manufacture of insecticides and acaricides |
| EP2232995A1 (en) | 2009-03-25 | 2010-09-29 | Bayer CropScience AG | Method for improved utilisation of the production potential of transgenic plants |
| EP2239331A1 (en) | 2009-04-07 | 2010-10-13 | Bayer CropScience AG | Method for improved utilization of the production potential of transgenic plants |
| BRPI1015543A8 (en) | 2009-05-06 | 2016-05-24 | Bayer Cropscience Ag | CYCLOPENTANEDIONE COMPOUNDS AND THEIR USE AS INSECTICIDES, ACARICIDES AND/OR FUNGICIDES. |
| AR076839A1 (en) | 2009-05-15 | 2011-07-13 | Bayer Cropscience Ag | FUNGICIDE DERIVATIVES OF PIRAZOL CARBOXAMIDAS |
| EP2251331A1 (en) | 2009-05-15 | 2010-11-17 | Bayer CropScience AG | Fungicide pyrazole carboxamides derivatives |
| EP2255626A1 (en) | 2009-05-27 | 2010-12-01 | Bayer CropScience AG | Use of succinate dehydrogenase inhibitors to increase resistance of plants or parts of plants to abiotic stress |
| CN105165832B (en) | 2009-06-02 | 2019-08-13 | 拜耳知识产权有限责任公司 | Application of the succinate dehydrogenase inhibitors in control Sclerotinia fungi |
| WO2011006603A2 (en) | 2009-07-16 | 2011-01-20 | Bayer Cropscience Ag | Synergistic active substance combinations containing phenyl triazoles |
| WO2011015524A2 (en) | 2009-08-03 | 2011-02-10 | Bayer Cropscience Ag | Fungicide heterocycles derivatives |
| EP2292094A1 (en) | 2009-09-02 | 2011-03-09 | Bayer CropScience AG | Active compound combinations |
| EP2343280A1 (en) | 2009-12-10 | 2011-07-13 | Bayer CropScience AG | Fungicide quinoline derivatives |
| MX336392B (en) | 2009-12-28 | 2016-01-18 | Bayer Cropscience Ag | Fungicide hydroximoyl-heterocycles derivatives. |
| US20130012546A1 (en) | 2009-12-28 | 2013-01-10 | Christian Beier | Fungicide hydroximoyl-tetrazole derivatives |
| BR112012012107B1 (en) | 2009-12-28 | 2019-08-20 | Bayer Cropscience Ag | Compound, fungicidal composition and method for controlling plant pathogenic fungi |
| MA33933B1 (en) | 2010-01-22 | 2013-01-02 | Bayer Ip Gmbh | COMBINATIONS OF ACARICIDAL AND / OR INSECTICIDAL ACTIVE INGREDIENTS |
| CN102884054B (en) | 2010-03-04 | 2015-01-14 | 拜耳知识产权有限责任公司 | Fluoroalkyl-substituted 2-amidobenzimidazoles and the use thereof for boosting stress tolerance in plants |
| AR080827A1 (en) | 2010-04-06 | 2012-05-09 | Bayer Cropscience Ag | USE OF ACID 4- PHENYL-BUTIRICO AND / OR ITS SALTS FOR THE INCREASE OF STRESS TOLERANCE IN PLANTS |
| WO2011124553A2 (en) | 2010-04-09 | 2011-10-13 | Bayer Cropscience Ag | Use of derivatives of the (1-cyanocyclopropyl)phenylphosphinic acid, the esters thereof and/or the salts thereof for enhancing the tolerance of plants to abiotic stress |
| WO2011134911A2 (en) | 2010-04-28 | 2011-11-03 | Bayer Cropscience Ag | Fungicide hydroximoyl-tetrazole derivatives |
| BR112012027558A2 (en) | 2010-04-28 | 2015-09-15 | Bayer Cropscience Ag | '' Compound of formula (I), fungicidal composition and method for the control of crop phytogenic fungi '' |
| US20130116287A1 (en) | 2010-04-28 | 2013-05-09 | Christian Beier | Fungicide hydroximoyl-heterocycles derivatives |
| EP2576516B1 (en) | 2010-06-03 | 2014-12-17 | Bayer Intellectual Property GmbH | N-[(het)arylethyl)]pyrazole(thio)carboxamides and their heterosubstituted analogues |
| MX2012013896A (en) | 2010-06-03 | 2012-12-17 | Bayer Cropscience Ag | N-[(het)arylalkyl)] pyrazole (thio)carboxamides and their heterosubstituted analogues. |
| UA110703C2 (en) | 2010-06-03 | 2016-02-10 | Байєр Кропсайнс Аг | Fungicidal n-[(trisubstitutedsilyl)methyl]carboxamide |
| AU2011264074B2 (en) | 2010-06-09 | 2015-01-22 | Bayer Cropscience Nv | Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering |
| AU2011264075B2 (en) | 2010-06-09 | 2015-01-29 | Bayer Cropscience Nv | Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering |
| RU2013107369A (en) | 2010-07-20 | 2014-08-27 | Байер Кропсайенс Аг | Benzocycloalkenes as an anti-fungal agent |
| PL2611300T3 (en) | 2010-09-03 | 2016-10-31 | Substituted annelated dihydropyrimidinone compounds | |
| WO2012038480A2 (en) | 2010-09-22 | 2012-03-29 | Bayer Cropscience Ag | Use of biological or chemical control agents for controlling insects and nematodes in resistant crops |
| EP2460406A1 (en) | 2010-12-01 | 2012-06-06 | Bayer CropScience AG | Use of fluopyram for controlling nematodes in nematode resistant crops |
| WO2012045798A1 (en) | 2010-10-07 | 2012-04-12 | Bayer Cropscience Ag | Fungicide composition comprising a tetrazolyloxime derivative and a thiazolylpiperidine derivative |
| JP2013541554A (en) | 2010-10-21 | 2013-11-14 | バイエル・インテレクチユアル・プロパテイー・ゲー・エム・ベー・ハー | N-benzyl heterocyclic carboxamides |
| EP2630135B1 (en) | 2010-10-21 | 2020-03-04 | Bayer Intellectual Property GmbH | 1-(heterocyclic carbonyl) piperidines |
| EP2635564B1 (en) | 2010-11-02 | 2017-04-26 | Bayer Intellectual Property GmbH | N-hetarylmethyl pyrazolylcarboxamides |
| US20130231303A1 (en) | 2010-11-15 | 2013-09-05 | Bayer Intellectual Property Gmbh | 5-halogenopyrazole(thio)carboxamides |
| CN103313971B (en) | 2010-11-15 | 2015-12-02 | 拜耳知识产权有限责任公司 | N-Arylpyrazole(thio)carboxamides |
| WO2012065947A1 (en) | 2010-11-15 | 2012-05-24 | Bayer Cropscience Ag | 5-halogenopyrazolecarboxamides |
| EP2460407A1 (en) | 2010-12-01 | 2012-06-06 | Bayer CropScience AG | Agent combinations comprising pyridylethyl benzamides and other agents |
| AU2011334989A1 (en) | 2010-12-01 | 2013-06-13 | Bayer Intellectual Property Gmbh | Use of fluopyram for controlling nematodes in crops and for increasing yield |
| EP2474542A1 (en) | 2010-12-29 | 2012-07-11 | Bayer CropScience AG | Fungicide hydroximoyl-tetrazole derivatives |
| JP2014502611A (en) | 2010-12-29 | 2014-02-03 | バイエル・インテレクチユアル・プロパテイー・ゲー・エム・ベー・ハー | Fungicide hydroxymoyl-tetrazole derivative |
| EP2471363A1 (en) | 2010-12-30 | 2012-07-04 | Bayer CropScience AG | Use of aryl-, heteroaryl- and benzylsulfonamide carboxylic acids, -carboxylic acid esters, -carboxylic acid amides and -carbonitriles and/or its salts for increasing stress tolerance in plants |
| EP2494867A1 (en) | 2011-03-01 | 2012-09-05 | Bayer CropScience AG | Halogen-substituted compounds in combination with fungicides |
| EP2683239A1 (en) | 2011-03-10 | 2014-01-15 | Bayer Intellectual Property GmbH | Use of lipochito-oligosaccharide compounds for safeguarding seed safety of treated seeds |
| JP2014509599A (en) | 2011-03-14 | 2014-04-21 | バイエル・インテレクチユアル・プロパテイー・ゲー・エム・ベー・ハー | Fungicide hydroxymoyl-tetrazole derivative |
| US20140051575A1 (en) | 2011-04-08 | 2014-02-20 | Juergen Benting | Fungicide hydroximoyl-tetrazole derivatives |
| AR085568A1 (en) | 2011-04-15 | 2013-10-09 | Bayer Cropscience Ag | 5- (BICYCLE [4.1.0] HEPT-3-EN-2-IL) -PENTA-2,4-DIENOS AND 5- (BICYCLE [4.1.0] HEPT-3-EN-2-IL) -PENT- 2-IN-4-INOS REPLACED AS ACTIVE PRINCIPLES AGAINST ABIOTIC STRESS OF PLANTS |
| AR085585A1 (en) | 2011-04-15 | 2013-10-09 | Bayer Cropscience Ag | VINIL- AND ALQUINILCICLOHEXANOLES SUBSTITUTED AS ACTIVE PRINCIPLES AGAINST STRIPS ABIOTIQUE OF PLANTS |
| AR090010A1 (en) | 2011-04-15 | 2014-10-15 | Bayer Cropscience Ag | 5- (CICLOHEX-2-EN-1-IL) -PENTA-2,4-DIENOS AND 5- (CICLOHEX-2-EN-1-IL) -PENT-2-EN-4-INOS REPLACED AS ACTIVE PRINCIPLES AGAINST THE ABIOTIC STRESS OF PLANTS, USES AND TREATMENT METHODS |
| EP2511255A1 (en) | 2011-04-15 | 2012-10-17 | Bayer CropScience AG | Substituted prop-2-in-1-ol and prop-2-en-1-ol derivatives |
| JP5870186B2 (en) | 2011-04-22 | 2016-02-24 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH | Active compound combination comprising (thio) carboxamide derivative and fungicidal active compound |
| CN103597082B (en) | 2011-06-06 | 2017-09-15 | 拜尔作物科学公司 | For the ways and means in preselected site modified plant genome |
| US9173395B2 (en) | 2011-07-04 | 2015-11-03 | Bayer Intellectual Property Gmbh | Use of substituted isoquinolinones, isoquinolindiones, isoquinolintriones and dihydroisoquinolinones or in each case salts thereof as active agents against abiotic stress in plants |
| CN103717076B (en) | 2011-08-10 | 2016-04-13 | 拜耳知识产权股份有限公司 | Active compound combinations containing specific tetramic acid derivatives |
| CN103981149A (en) | 2011-08-22 | 2014-08-13 | 拜尔作物科学公司 | Methods and means to modify a plant genome |
| EP2748161A1 (en) | 2011-08-22 | 2014-07-02 | Bayer Intellectual Property GmbH | Fungicide hydroximoyl-tetrazole derivatives |
| EP2561759A1 (en) | 2011-08-26 | 2013-02-27 | Bayer Cropscience AG | Fluoroalkyl-substituted 2-amidobenzimidazoles and their effect on plant growth |
| RU2014113760A (en) | 2011-09-09 | 2015-10-20 | Байер Интеллекчуал Проперти Гмбх | Acyl-homoserine lactone derivatives for increasing crop yields |
| BR112014005471A2 (en) | 2011-09-12 | 2017-03-28 | Bayer Ip Gmbh | compounds of formula (i), (v), (vii), fungicidal composition, method for the control of crop phytopathogenic fungi, use of the compounds of formula (i) and process for the production of compositions for the control of phytopathogenic harmful fungi |
| CA2848620C (en) | 2011-09-16 | 2020-03-10 | Bayer Intellectual Property Gmbh | Use of cyprosulfamide for inducing a growth regulating response in useful plants and increasing the yield of harvested plant organs therefrom |
| AU2012307324A1 (en) | 2011-09-16 | 2014-03-06 | Bayer Intellectual Property Gmbh | Use of phenylpyrazolin-3-carboxylates for improving plant yield |
| PH12014500563A1 (en) | 2011-09-16 | 2022-05-02 | Bayer Ip Gmbh | Use of 5-phenyl-or 5-benzyl-2 isoxazoline-3 carboxylates for improving plant yield |
| US9226505B2 (en) | 2011-09-23 | 2016-01-05 | Bayer Intellectual Property Gmbh | 4-substituted 1-phenylpyrazole-3-carboxylic acid derivatives as agents against abiotic plant stress |
| ES2628436T3 (en) | 2011-10-04 | 2017-08-02 | Bayer Intellectual Property Gmbh | RNAi for the control of fungi and oomycetes by the inhibition of the sacropin dehydrogenase gene |
| WO2013050324A1 (en) | 2011-10-06 | 2013-04-11 | Bayer Intellectual Property Gmbh | Combination, containing 4-phenylbutyric acid (4-pba) or a salt thereof (component (a)) and one or more selected additional agronomically active compounds (component(s) (b)), that reduces abiotic plant stress |
| CN103958531B (en) | 2011-11-21 | 2016-12-28 | 拜耳知识产权有限责任公司 | Antifungal N [(trisubstituted silicyl) methyl] carboxamide derivative |
| BR112014013031A2 (en) | 2011-11-30 | 2017-06-13 | Bayer Ip Gmbh | compost, fungicidal composition and method for fungal control |
| CA2859467C (en) | 2011-12-19 | 2019-10-01 | Bayer Cropscience Ag | Use of anthranilic acid diamide derivatives for pest control in transgenic crops |
| US9556158B2 (en) | 2011-12-29 | 2017-01-31 | Bayer Intellectual Property Gmbh | Fungicidal 3-[(pyridin-2-ylmethoxyimino)(phenyl)methyl]-2-substituted-1,2,4-oxadiazol-5(2H)-one derivatives |
| JP5976837B2 (en) | 2011-12-29 | 2016-08-24 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH | Bactericidal 3-[(1,3-thiazol-4-ylmethoxyimino) (phenyl) methyl] -2-substituted-1,2,4-oxadiazol-5 (2H) -one derivatives |
| CN104244714B (en) | 2012-02-22 | 2018-02-06 | 拜耳农作物科学股份公司 | Use of succinate dehydrogenase inhibitors (SDHI) for controlling wood diseases in grapes |
| UA113198C2 (en) | 2012-02-27 | 2016-12-26 | COMBINATIONS OF ACTIVE COMPOUNDS | |
| WO2013139949A1 (en) | 2012-03-23 | 2013-09-26 | Bayer Intellectual Property Gmbh | Compositions comprising a strigolactame compound for enhanced plant growth and yield |
| JP2015517996A (en) | 2012-04-12 | 2015-06-25 | バイエル・クロップサイエンス・アーゲーBayer Cropscience Ag | N-acyl-2- (cyclo) alkylpyrrolidines and piperidines useful as fungicides |
| WO2013156560A1 (en) | 2012-04-20 | 2013-10-24 | Bayer Cropscience Ag | N-cycloalkyl-n-[(trisubstitutedsilylphenyl)methylene]-(thio)carboxamide derivatives |
| EP2838893B1 (en) | 2012-04-20 | 2019-03-13 | Bayer Cropscience AG | N-cycloalkyl-n-[(heterocyclylphenyl)methylene]-(thio)carboxamide derivatives |
| BR112014026203A2 (en) | 2012-04-23 | 2017-07-18 | Bayer Cropscience Nv | plant-directed genome engineering |
| US9375005B2 (en) | 2012-05-09 | 2016-06-28 | Bayer Cropscience Ag | 5-halogenopyrazole indanyl carboxamides |
| BR112014027643B1 (en) | 2012-05-09 | 2019-04-24 | Bayer Cropscience Ag | PIRAZOLE-INDANIL-CARBOXAMIDES. |
| EP2662370A1 (en) | 2012-05-09 | 2013-11-13 | Bayer CropScience AG | 5-Halogenopyrazole benzofuranyl carboxamides |
| EP2662361A1 (en) | 2012-05-09 | 2013-11-13 | Bayer CropScience AG | Pyrazol indanyl carboxamides |
| EP2662360A1 (en) | 2012-05-09 | 2013-11-13 | Bayer CropScience AG | 5-Halogenopyrazole indanyl carboxamides |
| EP2662363A1 (en) | 2012-05-09 | 2013-11-13 | Bayer CropScience AG | 5-Halogenopyrazole biphenylcarboxamides |
| EP2662362A1 (en) | 2012-05-09 | 2013-11-13 | Bayer CropScience AG | Pyrazole indanyl carboxamides |
| EP2662364A1 (en) | 2012-05-09 | 2013-11-13 | Bayer CropScience AG | Pyrazole tetrahydronaphthyl carboxamides |
| AR091104A1 (en) | 2012-05-22 | 2015-01-14 | Bayer Cropscience Ag | COMBINATIONS OF ACTIVE COMPOUNDS THAT INCLUDE A LIPO-CHYTOOLIGOSACARIDE DERIVATIVE AND A NEMATICIDE, INSECTICIDE OR FUNGICIDE COMPOUND |
| AU2013289301A1 (en) | 2012-07-11 | 2015-01-22 | Bayer Cropscience Ag | Use of fungicidal combinations for increasing the tolerance of a plant towards abiotic stress |
| US20150216168A1 (en) | 2012-09-05 | 2015-08-06 | Bayer Cropscience Ag | Use of substituted 2-amidobenzimidazoles, 2-amidobenzoxazoles and 2-amidobenzothiazoles or salts thereof as active substances against abiotic plant stress |
| EP2908639A1 (en) | 2012-10-19 | 2015-08-26 | Bayer Cropscience AG | Active compound combinations comprising carboxamide derivatives |
| CA2888559C (en) | 2012-10-19 | 2021-03-02 | Bayer Cropscience Ag | Method for enhancing tolerance to abiotic stress in plants using carboxamide or thiocarboxamide derivatives |
| AU2013333845B2 (en) | 2012-10-19 | 2017-06-08 | Bayer Cropscience Ag | Method of plant growth promotion using carboxamide derivatives |
| HRP20180540T1 (en) | 2012-10-19 | 2018-05-04 | Bayer Cropscience Ag | Method for treating plants against fungi resistant to fungicides using carboxamide or thiocarboxamide derivatives |
| EP2735231A1 (en) | 2012-11-23 | 2014-05-28 | Bayer CropScience AG | Active compound combinations |
| WO2014079957A1 (en) | 2012-11-23 | 2014-05-30 | Bayer Cropscience Ag | Selective inhibition of ethylene signal transduction |
| EP2925134B1 (en) | 2012-11-30 | 2019-12-25 | Bayer CropScience AG | Ternary fungicidal mixtures |
| EA030236B1 (en) | 2012-11-30 | 2018-07-31 | Байер Кропсайенс Акциенгезельшафт | Ternary fungicidal and pesticidal mixtures |
| UA116223C2 (en) | 2012-11-30 | 2018-02-26 | Байєр Кропсайєнс Акцієнгезелльшафт | Binary fungicidal mixtures |
| WO2014083031A2 (en) | 2012-11-30 | 2014-06-05 | Bayer Cropscience Ag | Binary pesticidal and fungicidal mixtures |
| CN104837351A (en) | 2012-11-30 | 2015-08-12 | 拜耳作物科学股份公司 | Binary fungicidal or pesticidal mixture |
| EP2740356A1 (en) | 2012-12-05 | 2014-06-11 | Bayer CropScience AG | Substituted (2Z)-5(1-Hydroxycyclohexyl)pent-2-en-4-inic acid derivatives |
| EP2928296A1 (en) | 2012-12-05 | 2015-10-14 | Bayer CropScience AG | Use of substituted 1-(aryl ethynyl)-, 1-(heteroaryl ethynyl)-, 1-(heterocyclyl ethynyl)- and 1-(cyloalkenyl ethynyl)-cyclohexanols as active agents against abiotic plant stress |
| EP2740720A1 (en) | 2012-12-05 | 2014-06-11 | Bayer CropScience AG | Substituted bicyclic and tricyclic pent-2-en-4-inic acid derivatives and their use for enhancing the stress tolerance in plants |
| AR093909A1 (en) | 2012-12-12 | 2015-06-24 | Bayer Cropscience Ag | USE OF ACTIVE INGREDIENTS TO CONTROL NEMATODES IN CULTURES RESISTANT TO NEMATODES |
| AR093996A1 (en) | 2012-12-18 | 2015-07-01 | Bayer Cropscience Ag | BACTERICIDAL COMBINATIONS AND BINARY FUNGICIDES |
| BR112015014307A2 (en) | 2012-12-19 | 2017-07-11 | Bayer Cropscience Ag | difluoromethyl nicotinic tetrahydronaphthyl carboxamides |
| US20160016944A1 (en) | 2013-03-07 | 2016-01-21 | Bayer Cropscience Aktiengesellschaft | Fungicidal 3--heterocycle derivatives |
| CN105121650A (en) | 2013-04-02 | 2015-12-02 | 拜尔作物科学公司 | Targeted genome engineering in eukaryotes |
| EP2984081B1 (en) | 2013-04-12 | 2017-08-09 | Bayer CropScience Aktiengesellschaft | Novel triazole derivatives |
| BR112015025331A2 (en) | 2013-04-12 | 2017-07-18 | Bayer Cropscience Ag | new triazolintiona derivatives |
| US20160058001A1 (en) | 2013-04-19 | 2016-03-03 | Bayer Cropscience Aktiengesellschaft | Method for improved utilization of the production potential of transgenic plants |
| BR112015025907A2 (en) | 2013-04-19 | 2017-07-25 | Bayer Cropscience Ag | binary insecticide or pesticide mixture |
| WO2014177514A1 (en) | 2013-04-30 | 2014-11-06 | Bayer Cropscience Ag | Nematicidal n-substituted phenethylcarboxamides |
| TW201507722A (en) | 2013-04-30 | 2015-03-01 | Bayer Cropscience Ag | N-(2-halogen-2-phenethyl)carboxamides as nematicides and endoparasiticides |
| US9770022B2 (en) | 2013-06-26 | 2017-09-26 | Bayer Cropscience Ag | N-cycloalkyl-N-[(bicyclylphenyl)methylene]-(thio)carboxamide derivatives |
| US20160150782A1 (en) | 2013-07-09 | 2016-06-02 | Bayer Cropscience Aktiengesellschaft | Use of selected pyridone carboxamides or salts thereof as active substances against abiotic plant stress |
| ES2705577T3 (en) | 2013-12-05 | 2019-03-26 | Bayer Cropscience Ag | Derivatives of N-cyclopropyl-N - {[2- (1-cyclopropyl substituted) phenyl] methylene} - (thio) carboxamide |
| US10071967B2 (en) | 2013-12-05 | 2018-09-11 | Bayer Cropscience Aktiengesellschaft | N-cycloalkyl-N-{[2-(1-substitutedcycloalkyl)phenyl]methylene}-(thio)carboxamide derivatives |
| AR101214A1 (en) | 2014-07-22 | 2016-11-30 | Bayer Cropscience Ag | CIANO-CICLOALQUILPENTA-2,4-DIENOS, CIANO-CICLOALQUILPENT-2-EN-4-INAS, CIANO-HETEROCICLILPENTA-2,4-DIENOS AND CYANO-HETEROCICLILPENT-2-EN-4-INAS REPLACED AS ACTIVE PRINCIPLES PLANTS ABIOTIC |
| AR103024A1 (en) | 2014-12-18 | 2017-04-12 | Bayer Cropscience Ag | SELECTED PYRIDONCARBOXAMIDS OR ITS SALTS AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANTS STRESS |
| AT518612B1 (en) * | 2015-02-06 | 2019-03-15 | Chemiefaser Lenzing Ag | Polysaccharide suspension, process for its preparation and its use |
| BR112017022000A2 (en) | 2015-04-13 | 2018-07-03 | Bayer Cropscience Ag | n-cycloalkyl-n- (biheterocyclylethylene) - (thio) carboxamide derivatives. |
| AU2016279062A1 (en) | 2015-06-18 | 2019-03-28 | Omar O. Abudayyeh | Novel CRISPR enzymes and systems |
| CN109688816A (en) | 2016-07-29 | 2019-04-26 | 拜耳作物科学股份公司 | Active compound combinations and methods for protecting plant propagation material |
| WO2018054832A1 (en) | 2016-09-22 | 2018-03-29 | Bayer Cropscience Aktiengesellschaft | Novel triazole derivatives |
| EP3515906A1 (en) | 2016-09-22 | 2019-07-31 | Bayer CropScience Aktiengesellschaft | Novel triazole derivatives and their use as fungicides |
| US20190225974A1 (en) | 2016-09-23 | 2019-07-25 | BASF Agricultural Solutions Seed US LLC | Targeted genome optimization in plants |
| WO2018064208A1 (en) | 2016-09-28 | 2018-04-05 | The Broad Institute, Inc. | Systematic screening and mapping of regulatory elements in non-coding genomic regions, methods, compositions, and applications thereof |
| EP3531833A2 (en) | 2016-10-26 | 2019-09-04 | Bayer CropScience Aktiengesellschaft | Use of pyraziflumid for controlling sclerotinia spp in seed treatment applications |
| CA3046145A1 (en) | 2016-12-08 | 2018-06-14 | Bayer Cropscience Aktiengesellschaft | Use of insecticides for controlling wireworms |
| EP3332645A1 (en) | 2016-12-12 | 2018-06-13 | Bayer Cropscience AG | Use of substituted pyrimidine diones or their salts as agents to combat abiotic plant stress |
| WO2018108627A1 (en) | 2016-12-12 | 2018-06-21 | Bayer Cropscience Aktiengesellschaft | Use of substituted indolinylmethyl sulfonamides, or the salts thereof for increasing the stress tolerance of plants |
| US11591601B2 (en) | 2017-05-05 | 2023-02-28 | The Broad Institute, Inc. | Methods for identification and modification of lncRNA associated with target genotypes and phenotypes |
| WO2018213726A1 (en) | 2017-05-18 | 2018-11-22 | The Broad Institute, Inc. | Systems, methods, and compositions for targeted nucleic acid editing |
| WO2019025153A1 (en) | 2017-07-31 | 2019-02-07 | Bayer Cropscience Aktiengesellschaft | USE OF SUBSTITUTED N-SULFONYL-N'-ARYLDIAMINOALKANES AND N-SULFONYL-N'-HETEROARYL DIAMINOALKANES OR THEIR SALTS TO INCREASE STRESSTOLERANCE IN PLANTS |
| WO2019060746A1 (en) | 2017-09-21 | 2019-03-28 | The Broad Institute, Inc. | Systems, methods, and compositions for targeted nucleic acid editing |
| EP3728575A4 (en) | 2017-12-22 | 2021-11-24 | The Broad Institute, Inc. | CAS12B SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETED DNA BASE EDITING |
| US10968257B2 (en) | 2018-04-03 | 2021-04-06 | The Broad Institute, Inc. | Target recognition motifs and uses thereof |
| BR112020024615A2 (en) | 2018-06-04 | 2021-03-02 | Bayer Aktiengesellschaft | herbicidal bicyclic benzoylpyrazoles |
| CA3124110A1 (en) | 2018-12-17 | 2020-06-25 | The Broad Institute, Inc. | Crispr-associated transposase systems and methods of use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3442676A (en) * | 1965-12-29 | 1969-05-06 | Fmc Corp | Method of preparing a stable wax dispersion using beta-1,4 glucan |
| JPH06287887A (en) * | 1993-03-31 | 1994-10-11 | Mitsubishi Paper Mills Ltd | Paper containing bacterial cellulose |
| JP3268057B2 (en) * | 1993-04-27 | 2002-03-25 | 三菱製紙株式会社 | Anti-counterfeit paper |
-
1996
- 1996-06-12 CA CA002257622A patent/CA2257622C/en not_active Expired - Fee Related
- 1996-06-12 WO PCT/US1996/010191 patent/WO1997047807A1/en not_active Ceased
- 1996-06-12 AU AU65414/96A patent/AU729286B2/en not_active Ceased
- 1996-06-12 EP EP96925260A patent/EP0904454A1/en not_active Withdrawn
- 1996-06-12 JP JP10501539A patent/JP2000512348A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997047807A1 (en) | 1997-12-18 |
| CA2257622A1 (en) | 1997-12-18 |
| AU729286B2 (en) | 2001-02-01 |
| JP2000512348A (en) | 2000-09-19 |
| AU6541496A (en) | 1998-01-07 |
| EP0904454A1 (en) | 1999-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2257622C (en) | Substitutes for modified starch in paper manufacture | |
| US5712107A (en) | Substitutes for modified starch and latexes in paper manufacture | |
| AU731253B2 (en) | Substitutes for modified starch in paper manufacture | |
| CA2257621C (en) | Substitutes for modified starch in paper manufacture | |
| US6825342B1 (en) | Plant starch composition | |
| US7429657B2 (en) | DNA molecules encoding enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing these molecules | |
| US6596928B1 (en) | Plants synthesizing a modified starch, the generation of the plants, their use, and the modified starch | |
| US6465203B2 (en) | Glucan-containing compositions and paper | |
| US6794558B1 (en) | Nucleic acid module coding for αglucosidase, plants that synthesize modified starch, methods for the production and use of said plants, and modified starch | |
| US6791010B1 (en) | Nucleic acid molecule coding for beta-amylase, plants synthesizing a modified starch, method of production and applications | |
| US6087559A (en) | Plant cells and plants transformed with Streptococcus mutans genes encoding wild-type or mutant glucosyltransferase B enzymes | |
| JP2003507034A (en) | Transgenic plant cells and plants with modified GBSSI and BE protein activity | |
| WO1997011188A1 (en) | Plants which synthesise a modified starch, process for the production thereof and modified starch | |
| US6127602A (en) | Plant cells and plants transformed with streptococcus mutans genes encoding wild-type or mutant glucosyltransferase D enzymes | |
| EP1048730A2 (en) | Streptococcus mutans glucosyltransferase B mutants | |
| EP1048729A2 (en) | Streptococcus mutans glucosyltransferase D mutants |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |